Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Head and Neck Cancer

Free Subscription Articles published in Radiother Oncol Retrieve available abstracts of 86 articles: HTML format Text format

Single Articles

January 2012
1. TOLEDANO I , Graff P, Serre A, Boisselier P, et al
   Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004-03.
   Radiother Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. BHIDE SA , Gulliford S, Schick U, Miah A, et al
   Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer.
   Radiother Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. TUAN JK , Ha TC, Ong WS, Siow TR, et al
   Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma.
   Radiother Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. LU SH , Cheng JC, Kuo SH, Lee JJ, et al
   Volumetric modulated arc therapy for nasopharyngeal carcinoma: A dosimetric comparison with TomoTherapy and step-and-shoot IMRT.
   Radiother Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. WARREN GW , Arnold SM, Valentino JP, Gal TJ, et al
   Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population.
   Radiother Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. CHEN L , Mao YP, Xie FY, Liu LZ, et al
   The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China.
   Radiother Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
7. ZENDA S , Matsuura K, Tachibana H, Homma A, et al
   Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy.
   Radiother Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
8. STIELER F , Wolff D, Schmid H, Welzel G, et al
   A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT.
   Radiother Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. NGUYEN NP , Krafft SP, Vinh-Hung V, Vos P, et al
   Feasibility of tomotherapy to reduce normal lung and cardiac toxicity for distal esophageal cancer compared to three-dimensional radiotherapy.
   Radiother Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
10. DELOUYA G , Igidbashian L, Houle A, Belair M, et al
    (18)F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. HENDRICKSON K , Phillips M, Smith W, Peterson L, et al
    Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: Potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. HAN C , Schiffner DC, Schultheiss TE, Chen YJ, et al
    Residual setup errors and dose variations with less-than-daily image guided patient setup in external beam radiotherapy for esophageal cancer.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. GREGOIRE V , Hamoir M, Chen C, Kane M, et al
    Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
14. EGELMEER AG , Velazquez ER, de Jong JM, Oberije C, et al
    Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: A cohort study based on 994 patients.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. NIJKAMP MM , Hoogsteen IJ, Span PN, Takes RP, et al
    Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. MADANI I , Duprez F, Boterberg T, Van de Wiele C, et al
    Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. TORTOCHAUX J , Tao Y, Tournay E, Lapeyre M, et al
    Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. BOURHIS J , Lapeyre M, Tortochaux J, Lusinchi A, et al
    Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trial.
    Radiother Oncol. 2011;100:56-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. MENEGAKIS A , Eicheler W, Yaromina A, Thames HD, et al
    Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours.
    Radiother Oncol. 2011;100:137-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
20. MAFTEI CA , Shi K, Bayer C, Astner ST, et al
    Comparison of (immuno-)fluorescence data with serial [(18)F]Fmiso PET/CT imaging for assessment of chronic and acute hypoxia in head and neck cancers.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. PRATESI N , Mangoni M, Mancini I, Paiar F, et al
    Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. BONNER JA , Yang ES, Trummell HQ, Nowsheen S, et al
    Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. SKVORTSOV S , Jimenez CR, Knol JC, Eichberger P, et al
    Radioresistant head and neck squamous cell carcinoma cells: Intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. NIJKAMP MM , Span PN, Hoogsteen IJ, van der Kogel AJ, et al
    Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. BLANCHARD P , Baujat B, Holostenco V, Bourredjem A, et al
    Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. HOLZ C , Niehr F, Boyko M, Hristozova T, et al
    Epithelial-mesenchymal-transition induced by EGFR activation interferes with cell migration and response to irradiation and cetuximab in head and neck cancer cells.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. SIMONE CB 2ND , Ly D, Dan TD, Ondos J, et al
    Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. NOWSHEEN S , Bonner JA, Yang ES
    The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
    Radiother Oncol. 2011;99:331-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. NANDURI LS , Maimets M, Pringle SA, van der Zwaag M, et al
    Regeneration of irradiated salivary glands with stem cell marker expressing cells.
    Radiother Oncol. 2011;99:367-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. EKE I , Cordes N
    Dual targeting of EGFR and focal adhesion kinase in 3D grown HNSCC cell cultures.
    Radiother Oncol. 2011;99:279-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. BUSK M , Walenta S, Mueller-Klieser W, Steiniche T, et al
    Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.
    Radiother Oncol. 2011;99:404-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. GURTNER K , Deuse Y, Butof R, Schaal K, et al
    Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression.
    Radiother Oncol. 2011;99:323-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
33. BEETZ I , Schilstra C, Burlage FR, Koken PW, et al
    Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: The role of dosimetric and clinical factors.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. LIU H , Lu L, Zhu Q, Hao Y, et al
    Cervical nodal metastases of unresectable thoracic esophageal squamous cell carcinoma: Characteristics of long-term survivors after concurrent chemoradiotherapy.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. SHAKAM A , Scrimger R, Liu D, Mohamed M, et al
    Dose-volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: a prospective multi-institutional trial.
    Radiother Oncol. 2011;99:101-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
36. OVERGAARD J
    Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
37. BOOMSMA MJ , Bijl HP, Langendijk JA
    Radiation-induced hypothyroidism in head and neck cancer patients: A systematic review.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. DOBLER B , Groeger C, Treutwein M, Alvarez-Moret J, et al
    Commissioning of volumetric modulated arc therapy (VMAT) in a dual-vendor environment.
    Radiother Oncol. 2011;99:86-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
39. LASSEN P , Eriksen JG, Krogdahl A, Therkildsen MH, et al
    The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. KANKAANRANTA L , Saarilahti K, Makitie A, Valimaki P, et al
    Boron neutron capture therapy (BNCT) followed by intensity modulated chemoradiotherapy as primary treatment of large head and neck cancer with intracranial involvement.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
41. KADESJO N , Nyholm T, Olofsson J
    A practical approach to diode based in vivo dosimetry for intensity modulated radiotherapy.
    Radiother Oncol. 2011;98:378-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. VOET PW , Dirkx ML, Teguh DN, Hoogeman MS, et al
    Does atlas-based autosegmentation of neck levels require subsequent manual contour editing to avoid risk of severe target underdosage? A dosimetric analysis.
    Radiother Oncol. 2011;98:373-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. LOCK M , Cao JQ, D'Souza DP, Hammond JA, et al
    Brachytherapy with permanent gold grain seeds for squamous cell carcinoma of the lip.
    Radiother Oncol. 2011;98:352-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
44. ZACKRISSON B , Nilsson P, Kjellen E, Johansson KA, et al
    Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN study.
    Radiother Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. HAWKINS MA , Aitken A, Hansen VN, McNair HA, et al
    Set-up errors in radiotherapy for oesophageal cancers--is electronic portal imaging or conebeam more accurate?
    Radiother Oncol. 2011;98:249-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
46. WALSH L , Gillham C, Dunne M, Fraser I, et al
    Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC).
    Radiother Oncol. 2011;98:38-41.
    PubMed     Text format     Related articles   
    
    
    
    
47. COMBS SE , Kalbe A, Nikoghosyan A, Ackermann B, et al
    Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region.
    Radiother Oncol. 2011;98:63-7.
    PubMed     Text format     Related articles   
    
    
    
    
48. LOIMU V , Collan J, Vaalavirta L, Back L, et al
    Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin.
    Radiother Oncol. 2011;98:34-7.
    PubMed     Text format     Related articles   
    
    
    
    
49. MESSMER MB , Thomsen A, Kirste S, Becker G, et al
    Xerostomia after radiotherapy in the head & neck area: long-term observations.
    Radiother Oncol. 2011;98:48-50.
    PubMed     Text format     Related articles   
    
    
    
    
50. HOFF CM , Hansen HS, Overgaard M, Grau C, et al
    The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy--results from the randomized DAHANCA 5 study.
    Radiother Oncol. 2011;98:28-33.
    PubMed     Text format     Related articles   
    
    
    
    
51. JINGU K , Kishimoto R, Mizoe JE, Hasegawa A, et al
    Malignant mucosal melanoma treated with carbon ion radiotherapy with concurrent chemotherapy: prognostic value of pretreatment apparent diffusion coefficient (ADC).
    Radiother Oncol. 2011;98:68-73.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
52. TAO Y , Rezai K, Brain E, Etessami A, et al
    A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. LAMERS-KUIJPER E , Heemsbergen W, Mourik van A, Rasch C, et al
    Sequentially delivered boost plans are superior to simultaneously delivered plans in head and neck cancer when the boost volume is located further away from the parotid glands.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. TRINKAUS M , Corry J, Rischin D
    Comparison of self-reported smoking status and physician-recorded smoking status among patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
55. TSELIS N , Ratka M, Vogt HG, Kolotas C, et al
    Hypofractionated accelerated CT-guided interstitial (192)Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. ROSENBLATT E , Jones G, Sur RK, Donde B, et al
    Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency.
    Radiother Oncol. 2010;97:488-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. BREEN SL , Zhang B
    Audit of an automated checklist for quality control of radiotherapy treatment plans.
    Radiother Oncol. 2010;97:579-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. OLIVER M , Gagne I, Bush K, Zavgorodni S, et al
    Clinical significance of multi-leaf collimator positional errors for volumetric modulated arc therapy.
    Radiother Oncol. 2010;97:554-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
59. YAMASHITA H , Okuma K, Wakui R, Kobayashi-Shibata S, et al
    Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma - A retrospective analysis.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. NIEDZIELSKA G , Niedzielski A, Toman D
    Voice after radiotherapy of the larynx carcinoma.
    Radiother Oncol. 2010;97:276-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. HOUWELING AC , van den Berg CA, Roesink JM, Terhaard CH, et al
    Magnetic resonance imaging at 3.0T for submandibular gland sparing radiotherapy.
    Radiother Oncol. 2010;97:239-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. SCOTT-BROWN M , Miah A, Harrington K, Nutting C, et al
    Evidence-based review: quality of life following head and neck intensity-modulated radiotherapy.
    Radiother Oncol. 2010;97:249-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. HO KF , Farnell DJ, Routledge JA, Burns MP, et al
    Comparison of patient-reported late treatment toxicity (LENT-SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapy.
    Radiother Oncol. 2010;97:270-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. OSKAM IM , Verdonck-de Leeuw IM, Aaronson NK, Kuik DJ, et al
    Quality of life as predictor of survival: a prospective study on patients treated with combined surgery and radiotherapy for advanced oral and oropharyngeal cancer.
    Radiother Oncol. 2010;97:258-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
65. ZHAO L , Wan Q, Zhou Y, Deng X, et al
    The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. LEE AW , Tung SY, Chan AT, Chappell R, et al
    A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. CHOE KS , Salama JK, Stenson KM, Blair EA, et al
    Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. ALEVRONTA E , Ahlberg A, Mavroidis P, al-Abany M, et al
    Dose-response relations for stricture in the proximal oesophagus from head and neck radiotherapy.
    Radiother Oncol. 2010;97:54-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. BEETZ I , Burlage FR, Bijl HP, Hoegen-Chouvalova O, et al
    The Groningen Radiotherapy-Induced Xerostomia questionnaire: development and validation of a new questionnaire.
    Radiother Oncol. 2010;97:127-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. DE RUYSSCHER D , Severin D, Barnes E, Baumann M, et al
    First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II.
    Radiother Oncol. 2010;97:36-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
71. CHOI W , Lee SW, Park SH, Ryu JS, et al
    Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. BHIDE SA , Gulliford S, Fowler J, Rosenfelder N, et al
    Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. WU SX , Cui TT, Zhao C, Pan JJ, et al
    A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. FANG FM , Tsai WL, Lee TF, Liao KC, et al
    Multivariate analysis of quality of life outcome for nasopharyngeal carcinoma patients after treatment.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. KOIWAI K , Shikama N, Sasaki S, Shinoda A, et al
    Validation of the Total Dysphagia Risk Score (TDRS) as a predictive measure for acute swallowing dysfunction induced by chemoradiotherapy for head and neck cancers.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. TROOST EG , Schinagl DA, Bussink J, Oyen WJ, et al
    Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours.
    Radiother Oncol. 2010;96:328-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
77. HURMUZLU M , Ovrebo K, Wentzel-Larsen T, Muren LP, et al
    High-dose preoperative chemoradiotherapy in esophageal cancer patients does not increase postoperative pulmonary complications: Correlation with dose-volume histogram parameters.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
78. LI C , Iida M, Dunn EF, Wheeler DL, et al
    Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. KHAN Z , Khan N, Tiwari RP, Patro IK, et al
    Down-regulation of survivin by oxaliplatin diminishes radioresistance of head and neck squamous carcinoma cells.
    Radiother Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. SKVORTSOVA I , Skvortsov S, Raju U, Stasyk T, et al
    Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse.
    Radiother Oncol. 2010;96:108-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
81. PEDERSON AW , Haraf DJ, Blair EA, Stenson KM, et al
    Chemoreirradiation for recurrent salivary gland malignancies.
    Radiother Oncol. 2010;95:308-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. WONG K , Huang SH, O'Sullivan B, Lockwood G, et al
    Point-of-care outcome assessment in the cancer clinic: audit of data quality.
    Radiother Oncol. 2010;95:339-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
83. CASTADOT P , Geets X, Lee JA, Christian N, et al
    Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation.
    Radiother Oncol. 2010;95:209-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. KODAIRA T , Fuwa N, Tachibana H, Nakamura T, et al
    Retrospective analysis of definitive radiotherapy for patients with superficial esophageal carcinoma: Consideration of the optimal treatment method with a focus on late morbidity.
    Radiother Oncol. 2010;95:234-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
85. GILLIES RS , Middleton MR, Blesing C
    A reply to evidence-based radiation oncology: oesophagus.
    Radiother Oncol. 2010;94:387-8.
    PubMed     Text format     Related articles   
    
    
    
    
86. ZILLI T , Nouet P, Casanova N, Betz M, et al
    Unilateral radiotherapy for tonsil cancer: potential dose distribution optimization with a simple two-field intensity-modulated radiation therapy beam arrangement.
    Radiother Oncol. 2010;94:334-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: